Skip to main content

KALA BIO, Inc 8-K, filed Nov 12, 2026

KALA BIO, Inc. (KALA)

8-K 2026-11-12 For: 2026-11-12
View Original
Added on November 13, 2026

About this 8-K

KALA BIO, Inc filed this 8-K on November 12, 2026.

KALA BIO will effect a 1-for-30 reverse stock split, reducing outstanding common shares from 19,339,786 to approximately 644,659; split-adjusted Nasdaq trading begins November 16, 2026 under KALA. AI summary

Items reported

  • Item 3.03: Change to shareholders' rights
  • Item 5.03: Charter or bylaw amendment, or fiscal year change
  • Item 8.01: Other events
  • Item 9.01: Financial statements and exhibits